Dr. Ritika Mahajan, MD

Dr. Mahajan practices at Presbyterian Hospital in Albuquerque, New Mexico, part of Presbyterian Healthcare Services.

Dr. Mahajan's NPI, 1285947283, was assigned on July 19, 2010. Dr. Mahajan holds Georgia license 82503.

Dr. Mahajan's primary practice is Presbyterian Hospital, at 1100 Central Avenue SE, Albuquerque, NM 87106 in Bernalillo County. The practice phone is (505) 724-8386.

Dr. Mahajan's primary practice is Presbyterian Hospital in Albuquerque, New Mexico, part of Presbyterian Healthcare Services. Dr. Mahajan is also affiliated with Piedmont Henry Hospital. The medical group on file is Presbyterian Medical Group. Dmand AI also links Dr. Mahajan to 3 more hospitals, 2 medical groups, 1 physician office, 1 group practice or clinic, 1 home health agency and 1 therapy and rehab clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mahajan practices, 9 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Mahajan's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Mahajan is licensed in Georgia.

CMS data shows 665 Medicare services from Dr. Mahajan across 12 procedure codes in 2024, for 312 Medicare patients. Medicare paid $43,023 for them.

CMS counts 312 Medicare patients who saw Dr. Mahajan in 2024. The largest group is 65 to 74, with 116 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 21% are also on Medicaid. Their average risk score is 1.63, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mahajan's median patient age at 62, with 65% women.

In 2024, Dr. Mahajan wrote 3,517 Medicare Part D claims for 544 patients. 89% of them were for generic drugs. CMS names the drug for 3,322 of them, across 57 drugs with 11 or more claims each, at $1,572,468 in total drug cost. In 2023, CMS named 3,336 claims across 53 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Mahajan for performance year 2024, reported through an alternative payment model (APM). Dr. Mahajan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mahajan as offering telehealth.

CMS Open Payments shows 480 general payments to Dr. Mahajan from 43 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Abbvie Inc. paid the most, $950.